Quantcast

Latest Albany Molecular Research Inc. Stories

2014-08-05 08:33:33

Total Revenue of $68.2 million, including Contract Revenue of $61.5 Million, up 15% ALBANY, N.Y., Aug. 5, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2014. Highlights: -- Second quarter contract revenue of $61.5 million, up 21% from 2013 -- Second quarter adjusted diluted EPS of $0.22 vs. $0.11 in 2013 -- Expanded second quarter contract margins to 27% from 16% in 2013 -- Acquired Oso...

2014-07-22 08:31:36

ALBANY, N.Y., July 22, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue second quarter financial results before the opening of the market on Tuesday, August 5, 2014. Following the release of its results, the company will host a conference call and simultaneous audio webcast at 10:00 a.m. ET. The conference call can be accessed by dialing 888-505-4375 (domestic calls) or 719-325-2323 (international calls) at 9:50 a.m. ET and entering passcode 9752010. The audio...

2014-07-01 16:29:58

ALBANY, N.Y., July 1, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners, LLC. The transaction is consistent with AMRI's strategy to be the preeminent supplier of custom and complex drug product development and manufacturing services to the pharmaceutical industry. OsoBio is recognized as a premier contract manufacturer of highly complex...

2014-06-23 08:28:43

ALBANY, N.Y., June 23, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in connection with AMRI's proposed acquisition of Oso Biopharmaceuticals Manufacturing, LLC ("OsoBio") was terminated by the United States Federal Trade Commission on June 20, 2014. As previously announced on June 2, 2014, AMRI entered into a definitive agreement to acquire all of the outstanding...

2014-06-03 08:32:17

ALBANY, N.Y., June 3, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the 2014 Wells Fargo Healthcare Conference on Tuesday, June 17, 2014 at 10:00 a.m. ET. A webcast of the presentation can be accessed at the Investor Relations' section of www.amriglobal.com, or at the following URL: http://cc.talkpoint.com/well001/061714a_ac/?entity=41_IMTDU1O The webcast will...

2014-06-02 08:30:51

- Significantly Expands Contract Manufacturing Capabilities to Include Commercial Scale Sterile Injectables - ALBANY, N.Y., June 2, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, LLC ("OsoBio") for $110 million in cash. OsoBio is recognized as a premier contract manufacturer of highly complex injectable drug products, including sterile...

2014-05-19 08:28:10

ALBANY, N.Y., May 19, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the Jefferies 2014 Global Healthcare Conference on Monday, June 2, 2014 at 3:30 p.m. ET. A webcast of the presentation can be accessed at the Investor Relations' section of www.amriglobal.com, or at the following URL: http://wsw.com/webcast/jeff82/amri. The webcast will be archived for 90 days...

2014-05-07 08:33:00

ALBANY, N.Y., May 7, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the UBS Global Healthcare Conference on Wednesday, May 21, 2014 at 11:00 a.m. ET. A webcast of the presentation can be accessed at the Investor Relations' section of www.amriglobal.com, or at the following URL: http://cc.talkpoint.com/ubsx001/051914a_ep/?entity=58_CPM7VRX The webcast will be...

2014-05-06 08:34:55

Contract Revenue Growth of 10% to $51.0 Million and Adjusted Diluted EPS of $0.16 ALBANY, N.Y., May 6, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2014. Highlights: -- First quarter contract revenue of $51.0 million, up 10% from 2013 -- First quarter royalties of $8.3 million vs. $12.9 million, influenced by generic Allegra entries in Japan, representing an $0.08 per diluted share EPS...

2014-04-22 08:33:15

ALBANY, N.Y., April 22, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue first quarter financial results before the opening of the market on Tuesday, May 6, 2014. Following the release of its results, the company will host a conference call and simultaneous audio webcast at 10:00 a.m. ET. The conference call can be accessed by dialing 888-438-5524 (domestic calls) or 719-325-2448 (international calls) at 9:50 a.m. ET and entering passcode 8361277. The audio...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related